← FDA Drug Approvals (Drugs@FDA)

CARMUSTINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2022-06-21

Drug application

FDA Application #

ANDA211011

Application type

Abbreviated New Drug Application (Generic)

Brand name

CARMUSTINE

Generic name

Carmustine

Active ingredients

CARMUSTINE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

NOVAST LABS

First approval

2022-06-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown